BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 9024706)

  • 1. Relationship between the recurrence of hepatocellular carcinoma (HCC) and serum alanine aminotransferase levels in hepatectomized patients with hepatitis C virus-associated cirrhosis and HCC.
    Tarao K; Takemiya S; Tamai S; Sugimasa Y; Ohkawa S; Akaike M; Tanabe H; Shimizu A; Yoshida M; Kakita A
    Cancer; 1997 Feb; 79(4):688-94. PubMed ID: 9024706
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Close association between high serum ALT and more rapid recurrence of hepatocellular carcinoma in hepatectomized patients with HCV-associated liver cirrhosis and hepatocellular carcinoma.
    Tarao K; Rino Y; Takemiya S; Tamai S; Ohkawa S; Sugimasa Y; Miyakawa K; Morinaga S; Yoshida M; Shibuya A; Kokubu S; Kakita A; Endo O
    Intervirology; 2000; 43(1):20-6. PubMed ID: 10773734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum alanine aminotransferase levels and survival after hepatectomy in patients with hepatocellular carcinoma and hepatitis C virus-associated liver cirrhosis.
    Tarao K; Rino Y; Takemiya S; Ohkawa S; Sugimasa Y; Miyakawa K; Tamai S; Masaki T; Hirokawa S; Kameda Y; Nagaoka T; Okamoto N; Kokubu S; Yoshida M; Kakita A
    Cancer Sci; 2003 Dec; 94(12):1083-90. PubMed ID: 14662024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new plasma biomarker enhance the clinical prediction of postoperative acute kidney injury in patients with hepatocellular carcinoma.
    Zhou X; Wang L; Wang G; Cheng X; Hu S; Ke W; Li M; Zhang Y; Song Z; Zheng Q
    Clin Chim Acta; 2017 Dec; 475():128-136. PubMed ID: 29031454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between high serum alanine aminotransferase levels and more rapid development and higher rate of incidence of hepatocellular carcinoma in patients with hepatitis C virus-associated cirrhosis.
    Tarao K; Rino Y; Ohkawa S; Shimizu A; Tamai S; Miyakawa K; Aoki H; Imada T; Shindo K; Okamoto N; Totsuka S
    Cancer; 1999 Aug; 86(4):589-95. PubMed ID: 10440686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Close association between high serum alanine aminotransferase levels and multicentric hepatocarcinogenesis in patients with hepatitis C virus-associated cirrhosis.
    Tarao K; Rino Y; Ohkawa S; Tamai S; Miyakawa K; Takakura H; Endo O; Yoshitsugu M; Watanabe N; Matsuzaki S
    Cancer; 2002 Mar; 94(6):1787-95. PubMed ID: 11920542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduction therapy of alanine aminotransferase levels prevent HCC development in patients with HCV-associated cirrhosis.
    Rino Y; Tarao K; Morinaga S; Ohkawa S; Miyakawa K; Hirokawa S; Masaki T; Tarao N; Yukawa N; Saeki H; Takanashi Y; Imada T
    Anticancer Res; 2006; 26(3B):2221-6. PubMed ID: 16821591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between sustained elevation of serum alanine aminotransferase and progression from cirrhosis to hepatocellular carcinoma: comparison in patients with hepatitis B virus- and hepatitis C virus-associated cirrhosis.
    Sato A; Kato Y; Nakata K; Nakao K; Daikoku M; Ishii N; Matsumoto T; Iseki K; Mazume H; Nagataki S
    J Gastroenterol Hepatol; 1996 Oct; 11(10):944-8. PubMed ID: 8912132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpressed cyclo-oxygenase-2 in the background liver is associated with the clinical course of hepatitis C virus-related cirrhosis patients after curative surgery for hepatocellular carcinoma.
    Morinaga S; Tarao K; Yamamoto Y; Nakamura Y; Rino Y; Miyakawa K; Ohkawa S; Akaike M; Sugimasa Y; Takemiya S
    J Gastroenterol Hepatol; 2007 Aug; 22(8):1249-55. PubMed ID: 17688665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Posthepatectomy hepatitis shortens tumor-free intervals in hepatitis C virus-associated hepatocellular carcinoma patients.
    Kobayashi S; Iwasaki K; Asano T; Ochiai T
    Int J Mol Med; 2002 Dec; 10(6):749-53. PubMed ID: 12430002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ursodiol use is possibly associated with lower incidence of hepatocellular carcinoma in hepatitis C virus-associated liver cirrhosis.
    Tarao K; Fujiyama S; Ohkawa S; Miyakawa K; Tamai S; Hirokawa S; Masaki T; Tanaka K
    Cancer Epidemiol Biomarkers Prev; 2005 Jan; 14(1):164-9. PubMed ID: 15668491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Higher Ratio of Serum Alpha-Fetoprotein Could Predict Outcomes in Patients with Hepatitis B Virus-Associated Hepatocellular Carcinoma and Normal Alanine Aminotransferase.
    Kim YI; Kim HS; Park JW
    PLoS One; 2016; 11(6):e0157299. PubMed ID: 27304617
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of continuous hepatitis with persistent hepatitis C viremia on outcome after resection of hepatocellular carcinoma.
    Kubo S; Nishiguchi S; Shuto T; Tanaka H; Tsukamoto T; Hirohashi K; Ikebe T; Wakasa K; Kuroki T; Kinoshita H
    Jpn J Cancer Res; 1999 Feb; 90(2):162-70. PubMed ID: 10189886
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors for recurrence after resection of hepatitis C virus-related hepatocellular carcinoma.
    Kubo S; Hirohashi K; Tanaka H; Tsukamoto T; Shuto T; Ikebe T; Yamamoto T; Wakasa K; Nishiguchi S; Kuroki T; Kinoshita H
    World J Surg; 2000 Dec; 24(12):1559-65. PubMed ID: 11193723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sustained low alanine aminotransferase levels can predict the survival for 10 years without hepatocellular carcinoma development in patients with hepatitis C virus-associated liver cirrhosis of child stage A.
    Tarao K; Rino Y; Ohkawa S; Endo O; Miyakawa K; Tamai S; Hirokawa S; Masaki T; Nagaoka T; Okamoto N; Tanaka K; Tarao N
    Intervirology; 2004; 47(2):65-71. PubMed ID: 15192269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatic function immediately after hepatectomy as a significant risk factor for early recurrence in hepatocellular carcinoma.
    Hanazaki K; Wakabayashi M; Sodeyama H; Kajikawa S; Amano J
    Hepatogastroenterology; 1999; 46(30):3201-7. PubMed ID: 10626186
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preoperative serum gamma-glutamyl transferase to alanine aminotransferase ratio is a convenient prognostic marker for Child-Pugh A hepatocellular carcinoma after operation.
    Ju MJ; Qiu SJ; Fan J; Zhou J; Gao Q; Cai MY; Li YW; Tang ZY
    J Gastroenterol; 2009; 44(6):635-42. PubMed ID: 19387533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of occult hepatitis B virus infection and prior hepatitis B virus infection on development of hepatocellular carcinoma in patients with liver cirrhosis due to hepatitis C virus.
    Adachi S; Shibuya A; Miura Y; Takeuchi A; Nakazawa T; Saigenji K
    Scand J Gastroenterol; 2008; 43(7):849-56. PubMed ID: 18584524
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic Value of ALT, AST, and AAR in Hepatocellular Carcinoma with B-Type Hepatitis-Associated Cirrhosis after Radical Hepatectomy.
    Zhou L; Wang SB; Chen SG; Qu Q; Rui JA
    Clin Lab; 2018 Oct; 64(10):1739-1747. PubMed ID: 30336532
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High serum alanine aminotransferase levels for the first three successive years can predict very high incidence of hepatocellular carcinoma in patients with Child Stage A HCV-associated liver cirrhosis.
    Miyakawa K; Tarao K; Ohshige K; Morinaga S; Ohkawa S; Okamoto N; Shibuya A; Adachi S; Miura Y; Fujiyama S; Miyase S; Tomita K
    Scand J Gastroenterol; 2009; 44(11):1340-8. PubMed ID: 19891585
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.